Petros Pharmaceuticals, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, EisnerAmper LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6384 USD | -0.41% | -10.50% | -54.72% |
EPS Revisions
- Stock Market
- Equities
- PTPI Stock
- News Petros Pharmaceuticals
- Petros Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt